SCHEMBL31048265

SCHEMBL31048265

OC[C@@H]1CC2C(CCN1)C2(F)F

nearest known ligand 0.32

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
AGL P35573 1/20 0.32
GBA2 Q9HCG7 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21736611 0.69 GABRA1 (0.32)
SCHEMBL17476076 0.69 AGL (0.38) AGLGBA2
SCHEMBL17476073 0.69 AGL (0.38) AGLGBA2
SCHEMBL2897023 0.69
SCHEMBL23018232 0.69
SCHEMBL23564432 0.69
SCHEMBL15909334 0.69
SCHEMBL17476075 0.69 AGL (0.38) AGLGBA2
SCHEMBL1569653 0.69
SCHEMBL2904129 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024178304-A1 KRAS MODULATORS ALTEROME THERAPEUTICS, INC. (US) 2024-08-29 WO disclosed